๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma

โœ Scribed by Mark G. Slomiany; Leigh Ann Black; Megan M. Kibbey; Melissa A. Tingler; Terry A. Day; Steven A. Rosenzweig

Book ID
116334270
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
597 KB
Volume
248
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Insulin-like growth factor-1 receptor in
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma
โœ Christine H. Chung; Paula R. Pohlmann; Mace L. Rothenberg; Brian B. Burkey; Joel ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 751 KB

## Abstract ## Background Recurrent head and neck squamous cell carcinoma (HNSCC) remains a difficult cancer to treat. Here, we describe a patient with HNSCC who had complete response to methotrexate (MTX) after progressing on multiple cytotoxic agents, cetuximab, and AMGโ€479 (monoclonal antibody

Epidermal growth factor receptor targete
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
โœ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 382 KB ๐Ÿ‘ 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR